Tomasello Alejandro, Zamarro Joaquín, Terceño Mikel, Diaz-Perez Jose, Bashir Saima, Gramegna Laura Ludovica, Requena Manuel, Diana Francesco, Rivera Eila, Dios Marta De, Hernández David, Sánchez Sonia, Galve Inyaki, Liebskind David S, Ribo Marc
From the Interventional Neuroradiology Section (A.T., M.R., F.D., M.D.D., D.H., M.R.), Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
Departamento de Medicina (A.T.), Universitat Autònoma de Barcelona, Barcelona, Spain.
AJNR Am J Neuroradiol. 2025 Mar 4;46(3):502-509. doi: 10.3174/ajnr.A8556.
The ANA thrombectomy system is a funnel catheter comprising a self-expanding coated funnel that works in conjunction with a standard stent retriever and is designed to locally restrict flow and reduce clot fragmentation. The ANAIS Study to Confirm the Safety and Performance of the ANA 5F Advanced Neurovascular Access investigated the performance of the ANA funnel catheter in patients with stroke.
Mechanical thrombectomy using the ANA device in combination with a stent retriever in subjects with acute ischemic stroke. This is a prospective, single-arm, multicenter study with blinded outcome assessment by an independent imaging Core Lab. Patients with anterior circulation stroke undergoing mechanical thrombectomy were eligible. The primary end point was successful reperfusion (expanded TICI 2b50-3) within 3 passes without rescue therapy. The safety end point combined symptomatic intracranial hemorrhage and severe adverse device effect.
Forty-three subjects were treated in 3 centers: mean age, 70.5 (SD, 13.1) years, 44.2% (19/43) women; median admission NIHSS score, 16.0 (range, 12.5-19.5). The primary end point was achieved in 70% (30/43) and 81% (26/32) in the intention-to-treat (ITT) and per-protocol (PP) populations, respectively. The rates of first pass expanded TICI 2c-3 were 44% (19/43) and 56% (18/32) in the ITT and PP populations, respectively. There were no severe adverse device effects/symptomatic ICH at 24 hours (0/43). When the funnel was deployed in the C1 segment of the internal carotid artery (Bouthillier Classification), the primary end point (ITT, 36%; PP, 57%) was lower than when deployed in the C2/C3 segments (ITT, 89%; PP, 100%; < .01), or in the C4 or above segments (ITT, 71%; PP, 77%; < .05). The primary end point was higher when continuous aspiration was applied from initiation of the retrieval maneuver (ITT, 81%; PP, 92%) compared with end-aspiration only (ITT, 36%; PP, 50%, < .01).
The ANA funnel catheter achieved high rates of reperfusion and first pass success, with a good safety profile. Successful reperfusion was superior when the funnel was deployed above the C1 segment of the ICA and clot retrieval was performed under continuous aspiration.
ANA血栓切除术系统是一种漏斗形导管,其包含一个可自膨胀的涂层漏斗,该漏斗与标准的支架取栓器协同工作,旨在局部限制血流并减少血栓破碎。ANAIS研究旨在确认ANA 5F先进神经血管通路的安全性和性能,该研究调查了ANA漏斗形导管在中风患者中的性能。
在急性缺血性中风患者中,使用ANA装置联合支架取栓器进行机械取栓。这是一项前瞻性、单臂、多中心研究,由独立的影像核心实验室进行盲法结局评估。接受机械取栓的前循环中风患者符合条件。主要终点是在3次操作内成功再灌注(扩展的脑梗死溶栓分级2b50 - 3级)且无需补救治疗。安全终点包括有症状的颅内出血和严重的器械不良效应。
3个中心共治疗了43例受试者:平均年龄70.5(标准差,13.1)岁,女性占44.2%(19/43);入院时美国国立卫生研究院卒中量表(NIHSS)评分中位数为16.0(范围,12.5 - 19.5)。在意向性分析(ITT)人群和符合方案(PP)人群中,主要终点分别在70%(30/43)和81%(26/32)的受试者中达成。在ITT人群和PP人群中,首次通过扩展的脑梗死溶栓分级2c - 3级的比例分别为44%(19/43)和56%(18/32)。24小时时无严重的器械不良效应/有症状的颅内出血(0/43)。当漏斗部署在内颈动脉(布蒂利耶分类法)的C1段时,主要终点(ITT,36%;PP,57%)低于部署在C2/C3段时(ITT,89%;PP,100%;P <.01),或部署在C4段及以上时(ITT,71%;PP,77%;P <.05)。与仅在取栓操作结束时抽吸相比,从取栓操作开始就持续抽吸时主要终点更高(ITT,81%;PP,92%)(ITT,36%;PP,50%,P <.01)。
ANA漏斗形导管实现了高再灌注率和首次通过成功率,且安全性良好。当漏斗部署在颈内动脉C1段上方且在持续抽吸下进行血栓取出时,成功再灌注效果更佳。